CA2138181A1 - Utilisation de certains analogues de la prostaglandine pour traiter le glaucome et l'hypertension oculaire - Google Patents

Utilisation de certains analogues de la prostaglandine pour traiter le glaucome et l'hypertension oculaire

Info

Publication number
CA2138181A1
CA2138181A1 CA 2138181 CA2138181A CA2138181A1 CA 2138181 A1 CA2138181 A1 CA 2138181A1 CA 2138181 CA2138181 CA 2138181 CA 2138181 A CA2138181 A CA 2138181A CA 2138181 A1 CA2138181 A1 CA 2138181A1
Authority
CA
Canada
Prior art keywords
mmol
composition
compound
formula
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2138181
Other languages
English (en)
Inventor
Verney L. Sallee
Louis Desantis Jr.
Paul W. Zinke
John E. Bishop
Peter G. Klimko
Robert D. Selliah
Thomas R. Dean
Mark R. Hellberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/167,470 external-priority patent/US5721273A/en
Application filed by Individual filed Critical Individual
Publication of CA2138181A1 publication Critical patent/CA2138181A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA 2138181 1993-12-15 1994-12-15 Utilisation de certains analogues de la prostaglandine pour traiter le glaucome et l'hypertension oculaire Abandoned CA2138181A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16774793A 1993-12-15 1993-12-15
US08/167,747 1993-12-15
US08/167,470 1993-12-15
US08/167,470 US5721273A (en) 1993-12-15 1993-12-15 Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US08/316,672 1994-09-30

Publications (1)

Publication Number Publication Date
CA2138181A1 true CA2138181A1 (fr) 1995-06-16

Family

ID=26863209

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2138181 Abandoned CA2138181A1 (fr) 1993-12-15 1994-12-15 Utilisation de certains analogues de la prostaglandine pour traiter le glaucome et l'hypertension oculaire

Country Status (2)

Country Link
JP (1) JP2769294B2 (fr)
CA (1) CA2138181A1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170258B1 (fr) * 1984-07-31 1989-12-27 Syntex (U.S.A.) Inc. Dérivés 11-substitués-16-phénoxy et 16-phénoxy substitués de l'acide prostatriénoique
DE3510978A1 (de) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0242580B1 (fr) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Utilisation des prostaglandines A,B et C, et leurs dérivés pour le traitement de l'hypertension oculaire et du glaucome
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
JPH0739344B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
WO1994005631A1 (fr) * 1992-08-31 1994-03-17 Schering Aktiengesellschaft Esters et amides de 9-chlore-prostaglandine et leur utilisation pour preparer des medicaments

Also Published As

Publication number Publication date
JP2769294B2 (ja) 1998-06-25
JPH10120572A (ja) 1998-05-12

Similar Documents

Publication Publication Date Title
EP0783308B1 (fr) Utilisation de derives de la 9-desoxy prostaglandine pour traiter le glaucome
EP1920764B2 (fr) Ester isopropylique de fluprosténol dans le traitement du glaucome et de l'hypertension oculaire
ES2225897T3 (es) Analogos de tetrahidrofurano sustituido de prostaglandinas como hipotensores oculares.
US6353000B1 (en) 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
US5807892A (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
EP0667160A2 (fr) Utilisation d'analogues de prostaglandines pour le traitement de hypertension oculaire et le glaucome
US6344581B1 (en) Method of prostaglandin synthesis
CA2138181A1 (fr) Utilisation de certains analogues de la prostaglandine pour traiter le glaucome et l'hypertension oculaire
EP0686628A2 (fr) Esters de prostaglandine F
HK1014162A (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO1991013869A1 (fr) Derive de 15-desoxyprostaglandine
JPH06220011A (ja) １３，１４−ジヒドロ−９−エピ−プロスタグランジン▲ｄ２▼イソプロピルエステル、その製造方法およびそれを含有する薬剤
CA2201294A1 (fr) Utilisation de derives de la 9-desoxy prostaglandine pour traiter le glaucome
JPH07309833A (ja) プロスタグランジンｆエステル、その製造方法およびそれを含有する薬剤
HK1072716B (en) A topical fluprostenol ophthalmic composition for the treatment of glaucoma and ocular hypertension
HK1111636A1 (en) Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension
HK1111636B (en) Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension
HK1010717B (en) Use of fluprostenol isopropyl ester for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead